These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1371227)

  • 1. Biological activities of vitreous gel, retrohyaloid fluid and subretinal fluid from diabetic and non-diabetic eyes.
    Boulton M; Moriarty P; Gregor ZJ
    Br J Ophthalmol; 1992 Feb; 76(2):79-83. PubMed ID: 1371227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concentration of vascular endothelial growth factor within the subretinal space and vitreous fluid in rhegmatogenous retinal detachment].
    Moromizato Y; Hayashi H; Kato H; Ozaki H; Oshima K
    Nippon Ganka Gakkai Zasshi; 1997 Jun; 101(6):498-502. PubMed ID: 9209137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High subretinal fluid procoagulant activity in rhegmatogenous retinal detachment.
    Ricker LJ; Dieri RA; Beckers GJ; Pels E; Liem AT; Hendrikse F; Kijlstra A; Hemker HC; La Heij EC
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5234-9. PubMed ID: 20435588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIMP-1 and TIMP-2 levels in vitreous and subretinal fluid.
    Matsuo T; Okada Y; Shiraga F; Yanagawa T
    Jpn J Ophthalmol; 1998; 42(5):377-80. PubMed ID: 9822966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The insulin concentration in human ocular fluids.
    Feman SS; Turinsky J; Lam KW
    Am J Ophthalmol; 1978 Mar; 85(3):387-91. PubMed ID: 655218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
    Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
    N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological vitreous causes cell line-derived (but not donor-derived) retinal pigment epithelial cells to display proliferative vitreoretinopathy-like features in culture.
    Sharma M; Tiwari A; Sharma S; Bansal R; Gupta V; Gupta A; Luthra-Guptasarma M
    Clin Exp Ophthalmol; 2014 Nov; 42(8):745-60. PubMed ID: 24612444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of human intraocular fluid on vascular endothelial cell migration.
    Glaser BM; D'Amore PA; Michels RG
    Ophthalmology; 1981 Sep; 88(9):986-91. PubMed ID: 7301316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subretinal fluid in primary rhegmatogenous retinal detachment: physiopathology and composition.
    Quintyn JC; Brasseur G
    Surv Ophthalmol; 2004; 49(1):96-108. PubMed ID: 14711443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Subretinal proliferation and rhegmatogenous retinal detachment].
    Bonnet M; Hajjar C; Fleury J
    J Fr Ophtalmol; 1993; 16(4):235-40. PubMed ID: 8326103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of the vitreous body in diabetic retinopathy].
    Hendrikse F; Yeo KT
    Klin Monbl Augenheilkd; 1993 Nov; 203(5):319-23. PubMed ID: 8114473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multimodal Approaches for the Analysis of Retinal Functional Disorders―Focusing on Retinal Detachment].
    Terasaki H
    Nippon Ganka Gakkai Zasshi; 2017 Mar; 121(3):185-231. PubMed ID: 30088405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulins in paired specimens of vitreous and subretinal fluids from patients with rhegmatogenous retinal detachment.
    Rose GE; Billington BM; Chignell AH
    Br J Ophthalmol; 1990 Mar; 74(3):160-2. PubMed ID: 2322514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy.
    Danser AH; van den Dorpel MA; Deinum J; Derkx FH; Franken AA; Peperkamp E; de Jong PT; Schalekamp MA
    J Clin Endocrinol Metab; 1989 Jan; 68(1):160-7. PubMed ID: 2642484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased nitric oxide (NO) pathway metabolites in the vitreous fluid of patients with rhegmatogenous retinal detachment or diabetic traction retinal detachment.
    Diederen RM; La Heij EC; Deutz NE; Kessels AG; van Eijk HM; Hendrikse F
    Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):683-8. PubMed ID: 16267670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of microvascular endothelial cell proliferation by vitreous following retinal scatter photocoagulation.
    Singh A; Boulton M; Lane C; Forrester J; Gaal J; McLeod D
    Br J Ophthalmol; 1990 Jun; 74(6):328-32. PubMed ID: 1696121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protein composition of the vitreous body in proliferative diabetic retinopathy. An analysis with 2-D-electrophoresis].
    Bresgen M; Baum U; Esser P; Wiedemann P; Heimann K
    Ophthalmologe; 1994 Dec; 91(6):758-62. PubMed ID: 7849428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular neovascularization. Tissue culture studies.
    Gu XQ; Fry GL; Lata GF; Packer AJ; Servais EG; Hoak JC; Hayreh SS
    Arch Ophthalmol; 1985 Jan; 103(1):111-7. PubMed ID: 2579627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
    Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
    Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.